Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking ...

March 7, 2025 /PRNewswire/ -- Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology.

ORLANDO, FL (March 7, 2025) — Philadelphia-based board-certified dermatologist Susan C. Taylor, MD, FAAD, will begin her one-year term as president of the American Academy of Dermatology at the close ...

Amid limited access to pediatric dermatologists nationwide, pediatric patients of color with atopic dermatitis (AD) are ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...

Recent refinements to a multiphase approach to delusional infestations make this treatment protocol effective even within a ...

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of ...

Q32 Bio (QTTB) announced additional results from Part A of its SIGNAL-AA Phase 2a clinical trial of bempikibart in patients with alopecia ...

Larry Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children's Hospital, presented a session at ...

Boni Elewski, M.D., professor and chair of the University of Alabama at Birmingham Department of Dermatology is the 2025 American Academy of Dermatology Gold Medal Award.